It is well established that the ERs and PRs implicated in the progression of breast cancer (Schuetz et al., 2011), further the lack of ERs and PRs has been associated with aggressive phenotype, lymph node involvement, tumor size and tumor grade (Ayadi et al., 2008). This evidence concerns the gene WNK3 and neoplasm.